209 related articles for article (PubMed ID: 26420628)
1. Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.
Hsu JF; Chang HL; Tsai MJ; Tsai YM; Lee YL; Chen PH; Fan WC; Su YC; Yang CJ
World J Surg Oncol; 2015 Sep; 13():288. PubMed ID: 26420628
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of infectious complications related to implantable venous-access ports.
Shim J; Seo TS; Song MG; Cha IH; Kim JS; Choi CW; Seo JH; Oh SC
Korean J Radiol; 2014; 15(4):494-500. PubMed ID: 25053910
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
[TBL] [Abstract][Full Text] [Related]
4. Implantable venous port-related infections in cancer patients.
Huang WT; Chen TY; Su WC; Yen CJ; Tsao CJ
Support Care Cancer; 2004 Mar; 12(3):197-201. PubMed ID: 14727170
[TBL] [Abstract][Full Text] [Related]
5. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
7. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
8. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients.
Cairo J; Hachem R; Rangaraj G; Granwehr B; Raad I
Clin Microbiol Infect; 2011 Nov; 17(11):1711-6. PubMed ID: 21595787
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients.
Wang TY; Lee KD; Chen PT; Chen MC; Chen YY; Huang CE; Kuan FC; Chen CC; Lu CH
J Formos Med Assoc; 2015 Nov; 114(11):1055-60. PubMed ID: 26253646
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and risk factors for bloodstream infections in a home parenteral nutrition program.
Elfassy S; Kassam Z; Amin F; Khan KJ; Haider S; Armstrong D
JPEN J Parenter Enteral Nutr; 2015 Feb; 39(2):147-53. PubMed ID: 24072741
[TBL] [Abstract][Full Text] [Related]
11. Infections associated with indwelling ventriculostomy catheters in a teaching hospital.
Chi H; Chang KY; Chang HC; Chiu NC; Huang FY
Int J Infect Dis; 2010 Mar; 14(3):e216-9. PubMed ID: 19647466
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous port migration in a single institute in Taiwan.
Fan WC; Wu CH; Tsai MJ; Tsai YM; Chang HL; Hung JY; Chen PH; Yang CJ
World J Surg Oncol; 2014 Jan; 12():15. PubMed ID: 24423026
[TBL] [Abstract][Full Text] [Related]
13. Symptoms and signs of port-related infections in oncology patients related to the offending pathogens.
Liaw CC; Chen JS; Chang HK; Huang JS; Yang TS; Liau CT
Int J Clin Pract; 2008 Aug; 62(8):1193-8. PubMed ID: 18422589
[TBL] [Abstract][Full Text] [Related]
14. Catheter-associated bloodstream infections: looking outside of the ICU.
Marschall J
Am J Infect Control; 2008 Dec; 36(10):S172.e5-8. PubMed ID: 19084150
[TBL] [Abstract][Full Text] [Related]
15. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
16. Use of port-a-cath in cancer patients: a single-center experience.
D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Zahid KF; Furrukh M; Burney IA; Al-Moundhri MS
J Infect Dev Ctries; 2014 Nov; 8(11):1476-82. PubMed ID: 25390061
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy.
Sasaki T; Harada S; Yamamoto S; Ohkushi D; Hayama B; Takeda K; Hoashi K; Shiotani J; Takehana K; Doi Y
PLoS One; 2020; 15(1):e0228396. PubMed ID: 31999762
[TBL] [Abstract][Full Text] [Related]
18. Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study.
Aspalter M; Lechner M; Linni K; Hitzl W; Hölzenbein T; Ofner D; Emmanuel K
Am Surg; 2014 Feb; 80(2):204-7. PubMed ID: 24480224
[No Abstract] [Full Text] [Related]
19. Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study.
Kılıç S; Soyer T; Karnak İ; Çiftçi AÖ; Tanyel FC; Şenocak ME
Turk J Pediatr; 2016; 58(2):187-194. PubMed ID: 27976560
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for implantable venous access port catheter fracture with internal jugular vein.
Ai N; Li L; Yin F; Li Z; Geng C; Yang G
Ann Palliat Med; 2020 Jan; 9(1):30-36. PubMed ID: 32005060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
